David Lowe

David Lowe has held various roles in the biotechnology and pharmaceutical industry. David is currently the SVP Biologics at Peptone since June 2023. Prior to this, they worked as the Vice President Research at Evox Therapeutics Ltd from October 2020 to June 2023. Before that, they held positions at AstraZeneca, where they served as the Senior Director, R&D from June 2019 to October 2020, and as a Senior Director from March 2019 to October 2020. David has also worked at MedImmune as a Senior Director from June 2015 to October 2020, as a Fellow from October 2011 to October 2020, and as a Principal Scientist from November 2009 to October 2011. Additionally, they have experience as a Senior Scientist at Cambridge Antibody Technology from November 1997 to September 2007.

David Lowe completed their PhD in Microbiology, Biotechnology, and Biochemistry and Molecular Biology from the University of Cambridge between 1994 and 1997.